The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

A Case of Breast Cancer Patient Experiencing Adriamycin Cytoxan and Taxol Side Effects Managed by Traditional Korean Medicine

한방치료를 통해 Adriamycin/Cytoxan 및 Taxol 항암제 부작용이 감소한 유방암 환자 증례보고

  • Park, Byung-Rok (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Park, Jae-Woo (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Cho, Chong-Kwan (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Yoo, Hwa-Seung (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University) ;
  • Lee, Yeon-Weol (East-West Cancer Center, Dunsan Oriental Hospital of Dae-Jeon University)
  • 박병록 (대전대학교 둔산한방병원 동서암센터) ;
  • 박재우 (대전대학교 둔산한방병원 동서암센터) ;
  • 조종관 (대전대학교 둔산한방병원 동서암센터) ;
  • 유화승 (대전대학교 둔산한방병원 동서암센터) ;
  • 이연월 (대전대학교 둔산한방병원 동서암센터)
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Progress : A 33 year old female patient diagnosed with left breast cancer stage II was admitted to EWCC (East-West Cancer Center) in November of 2009. She had planned chemotherapy. She was treated with herbal medicine, acupuncture, moxibustion and physiotherapy for a period of 4 months, from Nov 5th, 2009 to Feb 18th 2010. We evaluated the grade of chief complaints and performed blood tests periodically. Results : TKM alleviates symptoms induced by anticancer chemotherapy. Nausea, headache, dizziness and chemotherapyinduced peripheral neuropathy were reduced. Quality of life was also upward. Conclusions : This case study supports TKM's potential efficacy in treating breast cancer patients suffering from anticancer chemotherapy.

Keywords

References

  1. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6(6) :229-39. https://doi.org/10.1186/bcr932
  2. The Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2008. Ministry of Health and Welfare; 2010.
  3. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353(17):1784-92. https://doi.org/10.1056/NEJMoa050518
  4. Byar KL, Berger AM, Bakken SL, Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum 2006;33(1):18-26. https://doi.org/10.1188/06.ONF.E18-E26
  5. Hassan BA, Yusoff ZB. Negative Impact of Chemotherapy on Breast Cancer Patients QOL - Utility of Antiemetic Treatment Guidelines and the Role of Race. Asian Pac J Cancer Prev 2010;11(6):1523-7.
  6. Cohen AJ, Menter A, Hale L. Acupuncture: Role in Comprehensive Cancer Care-A Primer for the Oncologist and Review of the Literature. Integr Cancer Ther 2005;4(2):131-43. https://doi.org/10.1177/1534735405276419
  7. Roscoe JA, Jean-Pierre P, Morrow GR, Hickok JT, Issell B, Wade JL, et al. Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected. J Soc Integr Oncol 2006;4(1):16-20.
  8. Park HM, Kim SY, Jung IC, Lee YW, Cho CK, Yoo HS. Integrative tumor board: a case report and discussion from East-West Cancer Center. Integr Cancer Ther 2010;9(2):236-45. https://doi.org/10.1177/1534735410371479
  9. Bang JW, Kim KS, Kim EY, Yoo HS, Lee YW, Cho CK, et al. Anti-angiogenic effects of the water extract of HangAmDan (WEHAD), a Korean traditional medicine. Sci China life Sci 2011;54(3):248-54. https://doi.org/10.1007/s11427-011-4144-3
  10. Giantonio BJ, Forastiere AA, Comis RL, The role of the Eastern Cooperative Oncology Group in establishing standards of cancer care: over 50 years of progress through clinical research. Semin Oncol 2008;35(5):494-506. https://doi.org/10.1053/j.seminoncol.2008.07.004